Presentation is loading. Please wait.

Presentation is loading. Please wait.

LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI LI-RADS version 2018 (v2018) had higher.

Published byHelen Shaw Modified over 5 years ago

Similar presentations

Presentation on theme: "LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI LI-RADS version 2018 (v2018) had higher."— Presentation transcript:

1 LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI LI-RADS version 2018 (v2018) had higher sensitivity for categorization of hepatocellular carcinomas (HCCs) as LR-5 on gadoxetate disodium–enhanced MRI vs LI-RADS version 2017 (v2017) (81% vs 68% respectively; P < .001). For small HCCs (10–19 mm), LI-RADS v2018 had higher sensitivity than LI-RADS v2017 (76% vs 11% respectively; P < .001). LR-5 criteria of LI-RADS v2018 had lower specificity than LI-RADS v2017 for diagnosis of small HCCs (10–19 mm) (94% vs 99%, respectively; P = .013). Axial images of gadoxetate-enhanced MRI in a 62-year-old man with chronic hepatitis B and HCC. Left – arterial phase; right – transitional phase. LR-5 nodule. Lee SM et al. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI. Published Online: July 16,

Download ppt "LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI LI-RADS version 2018 (v2018) had higher."

Similar presentations

DrMohammadSadrkabir Editor:. FREQUENCY OF ELEVATED HEPATOCELLULAR CARCINOMA (HCC) BIOMARKERS IN PATIENTS WITH ADVANCED HEPATITIS C The American Journal.

DrMohammadSadrkabir Editor:. FREQUENCY OF ELEVATED HEPATOCELLULAR CARCINOMA (HCC) BIOMARKERS IN PATIENTS WITH ADVANCED HEPATITIS C The American Journal.
Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),

Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),
Volume 71, Issue 5, Pages (May 2016)

Volume 71, Issue 5, Pages (May 2016)
LIVER MRI Kyung Hee University Hospital Hyoung Jung Kim

LIVER MRI Kyung Hee University Hospital Hyoung Jung Kim
Fig. 4. HCC with hepatobiliary phase (HBP) capsule appearance in 59-year-old female hepatitis B virus carrier. A. 2.8-cm tumor (arrow) in right posterior.

Fig. 4. HCC with hepatobiliary phase (HBP) capsule appearance in 59-year-old female hepatitis B virus carrier. A. 2.8-cm tumor (arrow) in right posterior.
Chapter 14 Hepatic Tumors, Malignant 1

Chapter 14 Hepatic Tumors, Malignant 1
Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography  Young–Joo Jin, So–Yun.

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography  Young–Joo Jin, So–Yun.
Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography  Young–Joo Jin, So–Yun.

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography  Young–Joo Jin, So–Yun.
Volume 55, Issue 1, Pages (July 2011)

Volume 55, Issue 1, Pages (July 2011)
Fig. 3. Sub-centimeter-sized HCC in 56-year-old man with chronic hepatitis B. Gadoxetic acid-enhanced MR image demonstrates 0.8-cm nodule (arrows) in right.

Fig. 3. Sub-centimeter-sized HCC in 56-year-old man with chronic hepatitis B. Gadoxetic acid-enhanced MR image demonstrates 0.8-cm nodule (arrows) in right.
Change in number of HCV-infected patients in different stages in both scenarios. Change in number of HCV-infected patients in different stages in both.

Change in number of HCV-infected patients in different stages in both scenarios. Change in number of HCV-infected patients in different stages in both.
Fig. 1. HCC in 56-year-old man. A

Fig. 1. HCC in 56-year-old man. A
MR of liver imaging: How I do it?

MR of liver imaging: How I do it?
Functional imaging in liver tumours

Functional imaging in liver tumours
Imaging in Liver Malignancy

Imaging in Liver Malignancy
Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial   When using CT to screen.

Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial   When using CT to screen.
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT Coronary microvascular.

Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT Coronary microvascular.
Effectiveness of Contrast-enhanced MR Angiography for Visualization of the Prostatic Artery prior to Prostatic Arterial Embolization Contrast-enhanced.

Effectiveness of Contrast-enhanced MR Angiography for Visualization of the Prostatic Artery prior to Prostatic Arterial Embolization Contrast-enhanced.
Use of Elastic Registration in Pulmonary MRI for the Assessment of Pulmonary Fibrosis in Patients with Systemic Sclerosis Areas of marked lung shrinkage.

Use of Elastic Registration in Pulmonary MRI for the Assessment of Pulmonary Fibrosis in Patients with Systemic Sclerosis Areas of marked lung shrinkage.
Fig. 2. HCC in 82-year-old man with chronic hepatitis C. A-C

Fig. 2. HCC in 82-year-old man with chronic hepatitis C. A-C

Similar presentations

Ads by Google